His primary areas of investigation include Internal medicine, Physical therapy, Randomized controlled trial, Odds ratio and Surgery. He interconnects Diabetes mellitus, Endocrinology, Type 2 diabetes and Cardiology in the investigation of issues within Internal medicine. Alex McConnachie has researched Physical therapy in several fields, including Body mass index, Intervention, Reference range, COPD and Prospective cohort study.
His Randomized controlled trial research is multidisciplinary, relying on both Clinical trial, Young adult, Quality of life, Placebo and Pediatrics. His study looks at the relationship between Odds ratio and fields such as Cross-sectional study, as well as how they intersect with chemical problems. His Surgery study combines topics from a wide range of disciplines, such as Stroke, Acute coronary syndrome, Pravastatin and Confidence interval.
Alex McConnachie spends much of his time researching Internal medicine, Randomized controlled trial, Physical therapy, Cardiology and Psychiatry. His Internal medicine research integrates issues from Diabetes mellitus and Endocrinology. Alex McConnachie has included themes like Blood pressure and Risk factor in his Diabetes mellitus study.
His research on Randomized controlled trial also deals with topics like
Alex McConnachie mainly focuses on Internal medicine, Randomized controlled trial, Cardiology, Myocardial infarction and Physical therapy. When carried out as part of a general Internal medicine research project, his work on Heart failure, Angina, Percutaneous coronary intervention and Clinical trial is frequently linked to work in In patient, therefore connecting diverse disciplines of study. His Randomized controlled trial research incorporates themes from Psychological intervention, Weight loss, Intervention, Quality of life and Referral.
The various areas that Alex McConnachie examines in his Weight loss study include Diabetes mellitus and Body mass index. In his study, which falls under the umbrella issue of Myocardial infarction, Conventional PCI is strongly linked to Placebo. His Physical therapy research is multidisciplinary, incorporating perspectives in Meta-analysis and Confidence interval.
The scientist’s investigation covers issues in Internal medicine, Randomized controlled trial, Cardiology, Physical therapy and Coronary artery disease. The study incorporates disciplines such as Diabetes mellitus and Type 2 diabetes in addition to Internal medicine. His Randomized controlled trial study integrates concerns from other disciplines, such as Intervention, Placebo, Odds ratio and Weight loss.
His Physical therapy study incorporates themes from Psychological intervention and Quality of life. His studies examine the connections between Quality of life and genetics, as well as such issues in Emergency medicine, with regards to Evidence-based practice and Informed consent. His study in Coronary artery disease is interdisciplinary in nature, drawing from both Artery, Angiography, Ischemia, Heart disease and Angina.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
Michael Ej Lean;Wilma S Leslie;Alison C Barnes;Naomi Brosnahan.
The Lancet (2017)
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies
Naveed Sattar;Alex McConnachie;A Gerald Shaper;Gerard J Blauw.
The Lancet (2008)
First year medical student stress and coping in a problem-based learning medical curriculum
Katrina J Moffat;Alex McConnachie;Sue Ross;Sue Ross;Jillian M Morrison.
Medical Education (2004)
Benefits of supervised group exercise programme for women being treated for early stage breast cancer: pragmatic randomised controlled trial
Nanette Mutrie;Anna M Campbell;Fiona Whyte;Alex McConnachie.
BMJ (2007)
Smoke-free legislation and hospitalizations for acute coronary syndrome
Jill Pell;Sally Haw;Stuart M Cobbe;David E Newby.
The New England Journal of Medicine (2008)
Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial
Michael E J Lean;Wilma S Leslie;Alison C Barnes;Naomi Brosnahan.
The Lancet Diabetes & Endocrinology (2019)
Effects and moderators of exercise on quality of life and physical function in patients with cancer : An individual patient data meta-analysis of 34 RCTs
Laurien M. Buffart;Joeri Kalter;Maike G. Sweegers;Kerry S. Courneya.
Cancer Treatment Reviews (2017)
Intergenerational 20 year trends in the prevalence of asthma and hay fever in adults: the Midspan family study surveys of parents and offspring
Mark N Upton;Alex McConnachie;Charles McSharry;Carole L Hart.
BMJ (2000)
Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism.
David J. Stott;Nicolas Rodondi;Patricia M. Kearney;Ian Ford.
The New England Journal of Medicine (2017)
Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial
Jane Elizabeth Norman;Neil Marlow;Claudia-Martina Messow;Andrew Shennan.
The Lancet (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Glasgow
University of Glasgow
University of Glasgow
University of Glasgow
University of Glasgow
University of Gothenburg
University of Bristol
University of Glasgow
University of Glasgow
University College London
University of Wisconsin–Madison
Intel (United States)
Wageningen University & Research
University of Cambridge
Imperial College London
University of Sheffield
University of Sheffield
Ghent University
University of Georgia
University of Granada
Grenoble Alpes University
US Forest Service
IHE Delft Institute for Water Education
Pohang University of Science and Technology
University of Padua
The University of Texas MD Anderson Cancer Center